Boston Scientific has agreed to acquire Nalu Medical, a company specializing in a novel neurostimulation device for chronic pain treatment, at a valuation of $600 million.

Target Information

Nalu Medical, a leading innovator in the medical technology sector, specializes in the development of a compact neurostimulation device designed to address chronic neuropathic pain. The company's flagship product provides a minimally invasive solution for patients seeking relief from persistent pain conditions, highlighting its potential impact on enhancing quality of life for individuals affected by such debilitating ailments.

Backed by Gilde Healthcare, Nalu Medical has successfully positioned itself within the healthcare market, demonstrating significant advancements in implant technology and patient care. This acquisition marks a pivotal moment for the company, allowing it to leverage Boston Scientific's extensive distribution networks and healthcare expertise.

Industry Overview

The medical technology industry in the Netherlands is characterized by a robust ecosystem of innovation and technology commercialization, fostering advancements that aim to improve patient outcom